Edison-based Pharmaceutical Formulations (OTC: PHFR) on Tuesday announced measures directed toward a recapitalization that would convert a significant portion of its current debt to equity. In a ...
BEIJING, Jan. 20, 2026 /PRNewswire/ -- "The recommendations for the 15th Five-Year Plan are the blueprint for China's economic and social development over the next five years and will unlock a growing ...
Apeiron Biologics is preparing to study an inhaled formulation of its ACE2 receptor decoy APN01. The clinical trial will test whether switching from intravenous to inhaled delivery can expand the ...
Information on 3 new studies from the 2026 R&D Program which are representative of the Company's primary areas of focus during at least the first three quarters of the calendar year, is being released ...
WATERTOWN, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening ...
KORONADAL CITY, South Cotabato (PIA) — The Regional Development Council (RDC) 12 has approved the formulation of the SOCCSKSARGEN Regional Physical Framework Plan (RPFP) for 2026–2056, an initiative ...
Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer In the article that accompanies this editorial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results